Osteoboost Secures $8M to Expand Access to its FDA-Cleared Prescription Wearable for Bone Health (opens in new tab)

Osteoboost Health today announced it has closed an $8 million financing round to scale manufacturing, expand clinical research, and broaden the commercial reach of the company’s FDA-cleared medical device for low bone density. The post Osteoboost Secures $8M to Expand Access to its FDA-Cleared Prescription Wearable for Bone Health appeared first on Orthopedics This Week.